Indications for liver transplantation

被引:150
作者
O'Leary, Jacqueline G. [1 ]
Lepe, Rita [1 ]
Davis, Gary L. [1 ]
机构
[1] Baylor Univ, Med Ctr, Dept Med, Dallas, TX 75246 USA
关键词
D O I
10.1053/j.gastro.2008.02.028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients should be considered for liver transplantation if they have evidence of fulminant hepatic failure, a life-threatening systemic complication of liver disease, or a liver-based metabolic defect or, more commonly, cirrhosis with complications such as hepatic encephalopathy, ascites, hepatocellular carcinoma, hepatorenal syndrome, or bleeding caused by portal hypertension. While the complications of cirrhosis can often be managed relatively effectively, they indicate a change in the natural history of the disease that should lead to consideration of liver transplantation. Referral to a liver transplant center is followed by a detailed. medical evaluation to ensure that transplantation is technically feasible, medically appropriate, and in the best interest of both the patient and society. Patients approved for transplantation are placed on a national transplant list, although donor organs are allocated locally and regionally. Since 2002, priority for transplantation has been determined by the Model of End-Stage Liver Disease (MELD) score, which provides donor organs to listed patients with the highest estimated short-term mortality.
引用
收藏
页码:1764 / 1776
页数:13
相关论文
共 95 条
[1]   The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]  
ALA A, 2004, CLIN LIVER DIS, P878
[3]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[4]  
ANGULO P, 2002, GASTROINTESTINAL LIV, P1474
[5]   Liver transplantation for alcoholic cirrhosis: Long term follow-up and impact of disease recurrence [J].
Bellamy, COC ;
DiMartini, AM ;
Ruppert, K ;
Jain, A ;
Dodson, F ;
Torbenson, M ;
Starzl, TE ;
Fung, JJ ;
Demetris, AJ .
TRANSPLANTATION, 2001, 72 (04) :619-626
[6]   Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation [J].
Berenguer, M ;
Prieto, M ;
Rayón, JM ;
Mora, J ;
Pastor, M ;
Ortiz, V ;
Carrasco, D ;
San Juan, F ;
Burgueño, MDJ ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2000, 32 (04) :852-858
[7]   More on serum phosphate and prognosis of acute liver failure [J].
Bernal, W ;
Wendon, J .
HEPATOLOGY, 2003, 38 (02) :533-534
[8]   Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study [J].
Bernal, W ;
Donaldson, N ;
Wyncoll, D ;
Wendon, J .
LANCET, 2002, 359 (9306) :558-563
[9]   MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS IN FULMINANT HEPATITIS-B [J].
BERNUAU, J ;
GOUDEAU, A ;
POYNARD, T ;
DUBOIS, F ;
LESAGE, G ;
YVONNET, B ;
DEGOTT, C ;
BEZEAUD, A ;
RUEFF, B ;
BENHAMOU, JP .
HEPATOLOGY, 1986, 6 (04) :648-651
[10]   Factors associated with advanced liver disease in adults with Alpha1-antitrypsin deficiency [J].
Bowlus, CL ;
Willner, I ;
Zern, MA ;
Reuben, A ;
Chen, P ;
Holladay, B ;
Xie, LQ ;
Woolson, RF ;
Strange, C .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (04) :390-396